75
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Bactericidal and immunomodulatory properties of magnetic nanoparticles functionalized by 1,4-dihydropyridines

, , , , , , , , & show all
Pages 3411-3424 | Published online: 11 Jun 2018

References

  • YangJJiangCYangJQianCFangDA clean procedure for the synthesis of 1,4-dihydropyridines via Hantzsch reaction in waterGreen Chem Lett Rev201363262267
  • Filipan-LitvićMLitvićMCepanecIVinkovićVHantzsch synthesis of 2,6-dimethyl-3,5-dimethoxycarbonyl-4-(o-methoxyphenyl)-1,4-dihydropyridine; a novel cyclisation leading to an unusual formation of 1-amino-2-methoxy-carbonyl-3,5-bis(o-methoxyphenyl)-4-oxa-cyclohexan-1-eneMolecules200712112546255818065957
  • KhedkarSAAutiPB1, 4-Dihydropyridines: a class of pharmacologically important moleculesMini Rev Med Chem201414328229024251802
  • YamagishiSNakamuraKTakenakaKMatsuiTInoueHPleiotropic effects of nifedipine on atherosclerosisCurr Pharm Des200612121543154716611134
  • TomaLStancuCSSandaGMSimaAVAnti-oxidant and anti-inflammatory mechanisms of amlodipine action to improve endothelial cell dysfunction induced by irreversibly glycated LDLBiochem Biophys Res Commun2011411120220721729693
  • PrasanthiGPrasadKVBharathiKSynthesis, anticonvulsant activity and molecular properties prediction of dialkyl 1-(di(ethoxycarbonyl) methyl)-2,6-dimethyl-4-substituted-1,4-dihydropyridine-3,5-dicarboxylatesEur J Med Chem2014739710424384550
  • KumarRSIdhayadhullaAAbdul NasserAJSelvinJSynthesis and anticoagulant activity of a new series of 1,4-dihydropyridine derivativesEur J Med Chem201146280481021220179
  • KumarRIdhayadhullaAAbdul NasserASelvinJSynthesis and antimicrobial activity of a new series of 1,4-dihydropyridine derivativesJ Serb Chem Soc2011761111
  • ReimãoJQScottiMTTemponeAGAnti-leishmanial and anti-trypanosomal activities of 1,4-dihydropyridines: in vitro evaluation and structure-activity relationship studyBioorg Med Chem201018228044805320934347
  • SirishaKAchaiahGReddyVMFacile synthesis and antibacterial, antitubercular, and anticancer activities of novel 1,4-dihydropyridinesArch Pharm (Weinheim)2010343634235220496343
  • ZorniakMMitregaKKrzeminskiTFDerivatives of 1,4-dihydropyri-dines as “priviledged structures” and their pharmacological potentialKardiol Pol201169suppl 3100103 Polish22125212
  • MarciniecBOgrodowczykMPhoto- and radiostability of some 1,4-dihydropyridine derivatives in the solid stateActa Pol Pharm200360215115513678328
  • ZhangDFlintOWangLCytochrome P450 11A1 bioactivation of a kinase inhibitor in rats: use of radioprofiling, modulation of metabolism, and adrenocortical cell lines to evaluate adrenal toxicityChem Res Toxicol201225355657122295996
  • MiriRJavidniaKAmirghofranZCytotoxic effect of some 1, 4-dihydropyridine derivatives containing nitroimidazole moietyIran J Pharm Res201110349750324250381
  • NiemirowiczKPiktelEWilczewskaAZCore-shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected cerageninsInt J Nanomedicine2016115443545527799768
  • NiemirowiczKDurnaśBTokajukGMagnetic nanoparticles as a drug delivery system that enhance fungicidal activity of polyene antibioticsNanomedicine20161282395240427464757
  • TaylorEWebsterTJReducing infections through nanotechnology and nanoparticlesInt J Nanomedicine201161463147321796248
  • NiemirowiczKDurnaśBPiktelEBuckiRDevelopment of antifungal therapies using nanomaterialsNanomedicine (Lond)201712151891190528703684
  • KiddTJMillsGSá-PessoaJA Klebsiella pneumoniae antibiotic resistance mechanism that subdues host defences and promotes virulenceEMBO Mol Med20179443044728202493
  • LoganLKWeinsteinRAThe epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menaceJ Infect Dis2017215suppl_1S28S3628375512
  • MassartRPreparation of aqueous magnetic liquids in alkaline and acidic mediaIEEE Trans Magn198117212471248
  • NiemirowiczKSwiecickaIWilczewskaAZGold-functionalized magnetic nanoparticles restrict growth of Pseudomonas aeruginosaInt J Nanomedicine201492217222424855358
  • MeletiadisJMoutonJWMeisJFComparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colo-rimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus speciesJ Clin Microbiol200139124256426311724829
  • YaoYOhkoYSekiguchiYFujishimaAKubotaYSelf-sterilization using silicone catheters coated with Ag and TiO2 nanocomposite thin filmJ Biomed Mater Res B Appl Biomater200885245346018098205
  • Hussein-Al-AliSHEl ZowalatyMEHusseinMZIsmailMWebsterTJSynthesis, characterization, controlled release, and antibacterial studies of a novel streptomycin chitosan magnetic nanoantibioticInt J Nanomedicine2014954955724549109
  • NiemirowiczKDurnaśBTokajukGFormulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13Sci Rep201771461028676673
  • SridharJKuriyanAEFlynnHWMillerDEndophthalmitis caused by Pseudomonas aeruginosa: clinical features, antibiotic susceptibilities, and treatment outcomesRetina20153561101110625658178
  • BarrerasUSMéndezFTMartínezREValenciaCSRodríguezPRRodríguezJPChitosan nanoparticles enhance the antibacterial activity of chlorhexidine in collagen membranes used for periapical guided tissue regenerationMater Sci Eng C Mater Biol Appl2016581182118726478419
  • FelicianiCGuptaAKSauderDNKeratinocytes and cytokine/growth factorsCrit Rev Oral Biol Med1996743003188986393
  • GloireGLegrand-PoelsSPietteJNF-kappaB activation by reactive oxygen species: fifteen years laterBiochem Pharmacol200672111493150516723122
  • DaviesJDaviesDOrigins and evolution of antibiotic resistanceMicrobiol Mol Biol Rev201074341743320805405
  • KatzAMLeachNMDifferential effects of 1,4-dihydropyridine calcium channel blockers: therapeutic implicationsJ Clin Pharmacol198727118258343323259
  • VijeshAMIsloorAMPeethambarSKShivanandaKNArulmoliTIsloorNAHantzsch reaction: synthesis and characterization of some new 1,4-dihydropyridine derivatives as potent antimicrobial and antioxidant agentsEur J Med Chem201146115591559721968373
  • BriedeJStivrinaMViganteBStoldereDDubursGAcute effect of antidiabetic 1,4-dihydropyridine compound cerebrocrast on cardiac function and glucose metabolism in the isolated, perfused normal rat heartCell Biochem Funct200826223824517990288
  • Núñez-VergaraLJSquellaJABollo-DragnicSNitro aryl 1,4-dihydropyridine derivatives: effects on Trypanosoma cruziComp Biochem Physiol C Pharmacol Toxicol Endocrinol199711811051119366041
  • SirishaKBikshapathiDAchaiahGReddyVMSynthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridinesEur J Med Chem20114651564157121382653
  • ChhillarAKAryaPMukherjeeCMicrowave-assisted synthesis of antimicrobial dihydropyridines and tetrahydropyrimidin-2-ones: novel compounds against aspergillosisBioorg Med Chem200614497398116214352
  • TasakaSOhmoriHGomiNSynthesis and structure – activity analysis of novel dihydropyridine derivatives to overcome multidrug resistanceBioorg Med Chem Lett200111227527711206476
  • MiriRMehdipourADihydropyridines and atypical MDR: a novel perspective of designing general reversal agents for both typical and atypical MDRBioorg Med Chem200816188329833418701304
  • HetzelDStraussWBernardKLiZUrbonieneAAllenLFA phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapyAm J Hematol201489664665024639149
  • NiemirowiczKMarkiewiczKHWilczewskaAZCarHMagnetic nanoparticles as new diagnostic tools in medicineAdv Med Sci201257219620723154427
  • PiktelENiemirowiczKWątekMWollnyTDeptułaPBuckiRRecent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapyJ Nanobiotechnology20161413927229857
  • AzamAAhmedASOvesMKhanMSHabibSSMemicAAntimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative studyInt J Nanomedicine201276003600923233805
  • LeubaKDDurmusNGTaylorENWebsterTJShort communication: carboxylate functionalized superparamagnetic iron oxide nanoparticles (SPION) for the reduction of S. aureus growth post biofilm formationInt J Nanomedicine2013873173623450111
  • AkbarzadehTFallah TaftiASamadiNSynthesis and cloxa-cillin antimicrobial enhancement of 2-methylsulfonylimidazolyl-1,4-dihydropyridine derivativesDaru201018211812322615605
  • BuckiRJanmeyPExtracellular aggregation of polyelectrolytes escaped from the cell interior: mechanisms and physiological consequencesCurr Opin Colloid Interface Sci2016268489
  • CieślukMPiktelEWątekMNeutrophil extracellular traps as the main source of eDNAMed Stud2017332137145
  • RudenSHilpertKBerditschMWadhwaniPUlrichASSynergistic interaction between silver nanoparticles and membrane-permeabilizing antimicrobial peptidesAntimicrob Agents Chemother20095383538354019528287